Arterio-venous access in end-stage renal disease patients and pulmonary hypertension.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2008, v. 2, n. 2, p. 49, doi. 10.1177/1753465808089456
- By:
- Publication type:
- Article
Works matching IS 17534658 AND DT 2008 AND VI 2 AND IP 2
Results: 6
1
2
Review: Treating patients with respiratory disease who smoke.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2008, v. 2, n. 2, p. 95, doi. 10.1177/1753465808089697
- By:
- Publication type:
- Article
3
Arformoterol and salmeterol in the treatment of chronic obstructive pulmonary disease: A one year evaluation of safety and tolerance.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2008, v. 2, n. 2, p. 37, doi. 10.1177/1753465808089455
- By:
- Publication type:
- Article
4
Exhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: A prospective study.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2008, v. 2, n. 2, p. 55, doi. 10.1177/1753465808088902
- By:
- Publication type:
- Article
5
Review: Surfactant protein D: A lung specific biomarker in COPD?
- Published in:
- Therapeutic Advances in Respiratory Disease, 2008, v. 2, n. 2, p. 65, doi. 10.1177/1753465808088903
- By:
- Publication type:
- Article
6
Review: New perspectives in the treatment of idiopathic pulmonary fibrosis.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2008, v. 2, n. 2, p. 75, doi. 10.1177/1753465808089363
- By:
- Publication type:
- Article